15476915

Source:http://linkedlifedata.com/resource/pubmed/id/15476915

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013227, umls-concept:C0018684, umls-concept:C0026769, umls-concept:C0087111, umls-concept:C1301732, umls-concept:C1524063
pubmed:issue	8
pubmed:dateCreated	2004-10-12
pubmed:abstractText	The aims of this study were to estimate the effects of demographics, location, severity of multiple sclerosis (MS), comorbidities, plan type, coinsurance levels, and time of entry into the sample on the use of disease-modifying agents.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7706726
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0149-2918
pubmed:author	pubmed-author:FinkelsteinStan NSN, pubmed-author:HawkinsKevinK, pubmed-author:MarderWilliam DWD, pubmed-author:OzminkowskiRonald JRJ, pubmed-author:SinskeyAnthony JAJ, pubmed-author:StallingsSarah CSC, pubmed-author:WangShaohungS, pubmed-author:WierzDavidD
pubmed:issnType	Print
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1341-54
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15476915-Adolescent, pubmed-meshheading:15476915-Adult, pubmed-meshheading:15476915-Aged, pubmed-meshheading:15476915-Child, pubmed-meshheading:15476915-Child, Preschool, pubmed-meshheading:15476915-Comorbidity, pubmed-meshheading:15476915-Deductibles and Coinsurance, pubmed-meshheading:15476915-Female, pubmed-meshheading:15476915-Health Planning, pubmed-meshheading:15476915-Humans, pubmed-meshheading:15476915-Immunologic Factors, pubmed-meshheading:15476915-Infant, pubmed-meshheading:15476915-Insurance, Pharmaceutical Services, pubmed-meshheading:15476915-Male, pubmed-meshheading:15476915-Middle Aged, pubmed-meshheading:15476915-Multiple Sclerosis, pubmed-meshheading:15476915-Prevalence, pubmed-meshheading:15476915-Proportional Hazards Models, pubmed-meshheading:15476915-Retrospective Studies, pubmed-meshheading:15476915-Severity of Illness Index, pubmed-meshheading:15476915-United States
pubmed:year	2004
pubmed:articleTitle	The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans.
pubmed:affiliation	Health and Productivity Management Research, Medstat, Ann Arbor, Michigan 48108, USA. ron.ozminkowski@medstat.com
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't